UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lp(a): a genetic cause of clinical FH in children

European heart journal, 2023-04, Vol.44 (16), p.1429-1431

2023

Volltextzugriff (PDF)

APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism

Current atherosclerosis reports, 2023-03, Vol.25 (3), p.67-76

2023

Volltextzugriff (PDF)

DeepSRE: Identification of sterol responsive elements and nuclear transcription factors Y proximity in human DNA by Convolutional Neural Network analysis

PloS one, 2021-03, Vol.16 (3), p.e0247402-e0247402

2021

Volltextzugriff (PDF)

Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy

Atherosclerosis, 2013-04, Vol.227 (2), p.342-348

2013

Volltextzugriff (PDF)

eNOS activation by HDL is impaired in genetic CETP deficiency

PloS one, 2014-05, Vol.9 (5), p.e95925-e95925

2014

Volltextzugriff (PDF)

Erdheim-Chester disease as complex clinical presentation and diagnosis: A case report and concise review of literature

Medicine (Baltimore), 2024-04, Vol.103 (17), p.e37870-e37870

2024

Volltextzugriff (PDF)

Novel LDL-cholesterol lowering therapies: A step forward a personalized medicine

European journal of internal medicine, 2023-06, Vol.112, p.19-20

2023

Volltextzugriff (PDF)

Therapeutic Options for Homozygous Familial Hypercholesterolemia: The Role of Lomitapide

Current medicinal chemistry, 2020-01, Vol.27 (23), p.3773-3783

2020

Volltextzugriff (PDF)

Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia

Atherosclerosis, 2015-07, Vol.241 (1), p.79-86

2015

Volltextzugriff (PDF)

Diagnosis of familial hypercholesterolemia in a large cohort of Italian genotyped hypercholesterolemic patients

Atherosclerosis, 2022-04, Vol.347, p.63-67

2022

Volltextzugriff (PDF)

Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia

Arteriosclerosis, thrombosis, and vascular biology, 2012-03, Vol.32 (3), p.805-809

2012

Volltextzugriff (PDF)

A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol

Arteriosclerosis, thrombosis, and vascular biology, 2007-03, Vol.27 (3), p.677-681

2007

Volltextzugriff (PDF)

Efficacy and safety of lomitapide in familial chylomicronaemia syndrome

Atherosclerosis, 2022-10, Vol.359, p.13-19

2022

Volltextzugriff (PDF)

Anti-PCSK9 treatment: is ultra-low low-density lipoprotein cholesterol always good?

Cardiovascular research, 2018-10, Vol.114 (12), p.1595-1604

2018

Volltextzugriff (PDF)

A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia

Arteriosclerosis, thrombosis, and vascular biology, 2013-08, Vol.33 (8), p.2021-2025

2013

Volltextzugriff (PDF)

Lifestyle versus ezetimibe plus lifestyle in patients with biopsy-proven non-alcoholic steatohepatitis (LISTEN): A double-blind randomised placebo-controlled trial

Nutrition, metabolism, and cardiovascular diseases, 2022-05, Vol.32 (5), p.1288-1291

2022

Volltextzugriff (PDF)

Molecular diagnosis of hypobetalipoproteinemia: An ENID review

Atherosclerosis, 2007-12, Vol.195 (2), p.e19-e27

2007

Volltextzugriff (PDF)

Effectiveness and safety of lomitapide in a patient with familial chylomicronemia syndrome

Endocrine, 2021-02, Vol.71 (2), p.344-350

2021

Volltextzugriff (PDF)

Circulating Molecular Chaperones in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabùt Aging Project

Journal of Alzheimer's disease, 2022-01, Vol.87 (1), p.161-172

2022

Volltextzugriff (PDF)

Beyond Statins: New Lipid Lowering Strategies to Reduce Cardiovascular Risk

Current atherosclerosis reports, 2014-06, Vol.16 (6), p.414-414, Article 414

2014

Volltextzugriff (PDF)

PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study

Atherosclerosis, 2020-01, Vol.292, p.209-214

2020

Volltextzugriff (PDF)

Myristic acid is associated to low plasma HDL cholesterol levels in a Mediterranean population and increases HDL catabolism by enhancing HDL particles trapping to cell surface proteoglycans in a liver hepatoma cell model

Atherosclerosis, 2016-03, Vol.246, p.50-56

2016

Volltextzugriff (PDF)

Individual analysis of patients with HoFH participating in a phase 3 trial with lomitapide: The Italian cohort

Nutrition, metabolism, and cardiovascular diseases, 2016-01, Vol.26 (1), p.36-44

2016

Volltextzugriff (PDF)

Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia

Arteriosclerosis, thrombosis, and vascular biology, 2015-12, Vol.35 (12), p.2694-2699

2015

Volltextzugriff (PDF)

Lack of phenotypic additive effect of familial defective apolipoprotein B3531 in familial hypercholesterolaemia

Internal medicine journal, 2021-04, Vol.51 (4), p.585-590

2021

Volltextzugriff (PDF)

1 – 25 von 245

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(209)

Publikationsform

Artikel
(242)
Berichte
(3)

Sprache

Englisch
(243)
Italienisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Lp(a): a genetic cause of clinical FH in children

APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism

DeepSRE: Identification of sterol responsive elements and nuclear transcription factors Y proximity in human DNA by Convolutional Neural Network analysis

Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy

eNOS activation by HDL is impaired in genetic CETP deficiency

Erdheim-Chester disease as complex clinical presentation and diagnosis: A case report and concise review of literature

Novel LDL-cholesterol lowering therapies: A step forward a personalized medicine

Therapeutic Options for Homozygous Familial Hypercholesterolemia: The Role of Lomitapide

Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia

Diagnosis of familial hypercholesterolemia in a large cohort of Italian genotyped hypercholesterolemic patients

Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia

A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol

Efficacy and safety of lomitapide in familial chylomicronaemia syndrome

Anti-PCSK9 treatment: is ultra-low low-density lipoprotein cholesterol always good?

A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia

Lifestyle versus ezetimibe plus lifestyle in patients with biopsy-proven non-alcoholic steatohepatitis (LISTEN): A double-blind randomised placebo-controlled trial

Molecular diagnosis of hypobetalipoproteinemia: An ENID review

Effectiveness and safety of lomitapide in a patient with familial chylomicronemia syndrome

Circulating Molecular Chaperones in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabùt Aging Project

Beyond Statins: New Lipid Lowering Strategies to Reduce Cardiovascular Risk

PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study

Myristic acid is associated to low plasma HDL cholesterol levels in a Mediterranean population and increases HDL catabolism by enhancing HDL particles trapping to cell surface proteoglycans in a liver hepatoma cell model

Individual analysis of patients with HoFH participating in a phase 3 trial with lomitapide: The Italian cohort

Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia

Lack of phenotypic additive effect of familial defective apolipoprotein B3531 in familial hypercholesterolaemia

Suchergebnisse filtern